{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:24:24Z","timestamp":1789853064974,"version":"4.0.1"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T00:00:00Z","timestamp":1368662400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0063548","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T21:20:12Z","timestamp":1368739212000},"page":"e63548","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Expression of the RNA Helicase DDX3 and the Hypoxia Response in Breast Cancer"],"prefix":"10.1371","volume":"8","author":[{"given":"Guus M.","family":"Bol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venu","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"van der Groep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen F.","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsken","family":"van der Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"van Diest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"J Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"ref2","unstructured":"Altekruse S, Kosary C, Krapcho M, Neyman N, Aminou R, <etal>et al<\/etal>.. (2010) SEER Cancer Statistics Review, 1975\u20132007, National Cancer Institute. Bethesda, MD, based on November 2009 SEER data submission, posted to the SEER web site. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/seercancergov\/csr\/1975_2007\/Accessed\" xlink:type=\"simple\">http:\/\/seercancergov\/csr\/1975_2007\/Accessed<\/ext-link> 2012 Nov."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"C Liedtke","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"R Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrm1335","article-title":"DEAD-box proteins: the driving forces behind RNA metabolism","volume":"5","author":"S Rocak","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0092-8674(02)00804-8","article-title":"RNA chaperones exist and DEAD box proteins get a life","volume":"109","author":"JR Lorsch","year":"2002","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2004.09.029","article-title":"Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function","volume":"119","author":"VS Yedavalli","year":"2004","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/viro.1999.9659","article-title":"Hepatitis C virus core protein interacts with a human DEAD box protein DDX3","volume":"257","author":"AM Owsianka","year":"1999","journal-title":"Virology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.bbrc.2004.01.151","article-title":"Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma","volume":"315","author":"JS Huang","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/cdd.2008.124","article-title":"Identification of an antiapoptotic protein complex at death receptors","volume":"15","author":"M Sun","year":"2008","journal-title":"Cell Death Differ"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1158\/0008-5472.CAN-05-4364","article-title":"Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function","volume":"66","author":"Y Li","year":"2006","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1038\/onc.2008.33","article-title":"Oncogenic role of DDX3 in breast cancer biogenesis","volume":"27","author":"M Botlagunta","year":"2008","journal-title":"Oncogene"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/sj.onc.1210687","article-title":"Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein","volume":"27","author":"JW Shih","year":"2007","journal-title":"Oncogene"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1093\/nar\/gkn454","article-title":"Human DDX3 functions in translation and interacts with the translation initiation factor eIF3","volume":"36","author":"CS Lee","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/ml100281b","article-title":"Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System","volume":"2","author":"A Kondaskar","year":"2010","journal-title":"ACS Med Chem Lett"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1021\/jm8008844","article-title":"Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3","volume":"51","author":"G Maga","year":"2008","journal-title":"J Med Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1021\/ol8020176","article-title":"The first synthesis of a novel 5:7:5-fused diimidazodiazepine ring system and some of its chemical properties","volume":"10","author":"R Kumar","year":"2008","journal-title":"Org Lett"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.bmcl.2011.12.135","article-title":"Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors","volume":"22","author":"M Radi","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1021\/bi901974a","article-title":"Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor","volume":"49","author":"CA Belon","year":"2010","journal-title":"Biochemistry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1021\/jm800332m","article-title":"Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication","volume":"51","author":"VS Yedavalli","year":"2008","journal-title":"J Med Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e17563","DOI":"10.1371\/journal.pone.0017563","article-title":"Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells","volume":"6","author":"M Botlagunta","year":"2011","journal-title":"PLoS ONE"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress","volume":"40","author":"AJ Majmundar","year":"2010","journal-title":"Molecular cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jnci\/93.4.309","article-title":"Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis","volume":"93","author":"R Bos","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.1038\/sj.onc.1206995","article-title":"Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1[alpha] (HIF-1[alpha])","volume":"22","author":"R Bos","year":"2003","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"R450","DOI":"10.1186\/bcr813","article-title":"Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related","volume":"6","author":"R Bos","year":"2004","journal-title":"Breast Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2559.2005.02045.x","article-title":"Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer","volume":"46","author":"R Bos","year":"2005","journal-title":"Histopathology"},{"key":"ref27","first-page":"43","article-title":"Hypoxia-induced acidification causes mitoxantrone resistance not mediated by drug transporters in human breast cancer cells","volume":"27","author":"AE Greijer","year":"2005","journal-title":"Cellular Oncology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10409230091169186","article-title":"Hypoxia, clonal selection, and the role of HIF-1 in tumor progression","volume":"35","author":"GL Semenza","year":"2000","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","article-title":"The role of hypoxia-induced factors in tumor progression","volume":"9","author":"P Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"25903","DOI":"10.1074\/jbc.M603414200","article-title":"Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression","volume":"281","author":"XH Peng","year":"2006","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","article-title":"HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression","volume":"21","author":"E Laughner","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"31277","DOI":"10.1074\/jbc.M300763200","article-title":"Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase\/Akt\/glycogen synthase kinase 3beta pathway in HepG2 cells","volume":"278","author":"D Mottet","year":"2003","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2004.06.020","article-title":"Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes","volume":"6","author":"J Brugarolas","year":"2004","journal-title":"Cancer Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1038\/sj.onc.1209643","article-title":"Hypoxia-inducible factor-1 alpha expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas","volume":"25","author":"EH Gort","year":"2006","journal-title":"Oncogene"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"11995","DOI":"10.1074\/jbc.273.20.11995","article-title":"p53 inhibits hypoxia-inducible factor-stimulated transcription","volume":"273","author":"MV Blagosklonny","year":"1998","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1073\/pnas.0911082107","article-title":"P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis","volume":"107","author":"M Yamakuchi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.14.1.34","article-title":"Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha","volume":"14","author":"R Ravi","year":"2000","journal-title":"Genes Dev"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/bj20031299","article-title":"p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1)","volume":"380","author":"T Schmid","year":"2004","journal-title":"Biochem J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature05602","article-title":"p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload","volume":"446","author":"M Sano","year":"2007","journal-title":"Nature"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1172\/JCI40583","article-title":"COMMD1 disrupts HIF-1alpha\/beta dimerization and inhibits human tumor cell invasion","volume":"120","author":"B van de Sluis","year":"2010","journal-title":"J Clin Invest"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e7332","DOI":"10.1371\/journal.pone.0007332","article-title":"COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90\/70","volume":"4","author":"B van de Sluis","year":"2009","journal-title":"PLoS ONE"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cellsig.2004.08.001","article-title":"Fer kinase sustains the activation level of ERK1\/2 and increases the production of VEGF in hypoxic cells","volume":"17","author":"Y Salem","year":"2005","journal-title":"Cell Signal"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ccr.2011.07.008","article-title":"A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression","volume":"20","author":"WC Yuan","year":"2011","journal-title":"Cancer Cell"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"30125","DOI":"10.1074\/jbc.M302042200","article-title":"The forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1 alpha by a von Hippel-Lindau protein-independent mechanism","volume":"278","author":"TT Tang","year":"2003","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/me.2001-0347","article-title":"Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells","volume":"16","author":"M Stoner","year":"2002","journal-title":"Mol Endocrinol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/me.2004-0162","article-title":"Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-1alpha in MCF-7 human breast cancer cells","volume":"19","author":"J Cho","year":"2005","journal-title":"Mol Endocrinol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"24142","DOI":"10.1074\/jbc.274.34.24142","article-title":"Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation","volume":"274","author":"L Tacchini","year":"1999","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.molcel.2007.10.035","article-title":"FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2","volume":"28","author":"WJ Bakker","year":"2007","journal-title":"Molecular cell"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/cdd.2011.95","article-title":"HIF-1 alpha is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway","volume":"19","author":"L Qiang","year":"2012","journal-title":"Cell Death and Differentiation"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.devcel.2005.09.010","article-title":"Hypoxia requires notch signaling to maintain the undifferentiated cell state","volume":"9","author":"MV Gustafsson","year":"2005","journal-title":"Dev Cell"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1158\/0008-5472.CAN-05-3719","article-title":"Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B","volume":"66","author":"B Krishnamachary","year":"2006","journal-title":"Cancer Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/sj.emboj.7600196","article-title":"HIF-1 alpha induces cell cycle arrest by functionally counteracting Myc","volume":"23","author":"M Koshiji","year":"2004","journal-title":"Embo Journal"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1535-6108(03)00085-0","article-title":"Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene","volume":"3","author":"S Pennacchietti","year":"2003","journal-title":"Cancer Cell"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/en.2005-0416","article-title":"Up-regulation of c-met protooncogene product expression through hypoxia-inducible factor-1alpha is involved in trophoblast invasion under low-oxygen tension","volume":"146","author":"M Hayashi","year":"2005","journal-title":"Endocrinology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/path.2244","article-title":"Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma","volume":"214","author":"N Horree","year":"2008","journal-title":"J Pathol"},{"key":"ref56","first-page":"1","article-title":"HER-2\/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization","volume":"31","author":"CB Moelans","year":"2009","journal-title":"Cellular oncology : the official journal of the International Society for Cellular Oncology"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"van der Groep P, Bouter A, van der Zanden R, Menko FH, Buerger H, <etal>et al<\/etal>.. (2004) Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 96: 712\u2013713; author reply 714.","DOI":"10.1093\/jnci\/djh114"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jcp.2004.019885","article-title":"Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer","volume":"58","author":"MM Vleugel","year":"2005","journal-title":"J Clin Pathol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10549-007-9817-z","article-title":"High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer","volume":"111","author":"P van der Groep","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1158\/0008-5472.CAN-08-1059","article-title":"The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors","volume":"68","author":"AB Brenkman","year":"2008","journal-title":"Cancer Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1158\/1055-9965.EPI-08-0472","article-title":"Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer","volume":"17","author":"EH Gort","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"e37864","DOI":"10.1371\/journal.pone.0037864","article-title":"Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer","volume":"7","author":"JF Vermeulen","year":"2012","journal-title":"PLoS ONE"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/bmj.325.7365.648","article-title":"For and against: No consent should be needed for using leftover body material for scientific purposes","volume":"325","author":"PJ van Diest","year":"2002","journal-title":"BMJ"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1099\/vir.0.015909-0","article-title":"Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein","volume":"91","author":"AG Angus","year":"2010","journal-title":"J Gen Virol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","article-title":"Clinical characteristics of different histologic types of breast cancer","volume":"93","author":"CI Li","year":"2005","journal-title":"Br J Cancer"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"e12293","DOI":"10.1371\/journal.pone.0012293","article-title":"Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer","volume":"5","author":"J Chen","year":"2010","journal-title":"PLoS ONE"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0063548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T06:30:23Z","timestamp":1645079423000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0063548"}},"subtitle":[],"editor":[{"given":"Sharon A.","family":"Glynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,16]]},"references-count":66,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0063548","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,16]]}}}